Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery

Area of Science:

• Oncology and Computational Chemistry
• Drug Discovery and Development

Background:

• Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies beyond conventional treatments.
• Traditional drug discovery methods like in vitro and in vivo studies are time-consuming and costly.
• The complexity of cancer necessitates advanced approaches for understanding disease mechanisms and identifying effective therapies.

Approach:

• This review explores computational drug discovery, including computer-aided drug design (CADD).
• Key CADD techniques discussed are target site prediction, structure- and ligand-based design, quantitative structure-activity relationship (QSAR) analysis, molecular docking, and molecular dynamics simulations.
• The role of artificial intelligence, databases, and computational tools in advancing anti-cancer drug discovery is examined.

Key Points:

• Computational methods, fueled by omics data, enable efficient anti-cancer drug discovery.
• CADD is pivotal for identifying novel drug targets and designing potential therapeutic agents.
• Successful examples of computationally designed drugs underscore the significance of these approaches.

Conclusions:

• Advanced CADD methods are essential for designing next-generation cancer therapies.
• Computational drug discovery accelerates the identification of effective and less toxic anti-cancer treatments.
• Integrating AI and computational tools is transforming the landscape of cancer drug development.